Age, years
|
38.8 (0.51)
|
Gender, male (%)
|
127 (66.5)
|
BMI, kg/m
2
|
22.93 (0.26)
|
Current smokers, n (%)
|
154 (80.6)
|
Lipodystrophy, n (%)
|
47 (24.1)
|
Time of sero-prevalence, years
|
4.29 (0.3)
|
Risk factors for HIV, n (%)
| |
Intravenous drug users
|
113 (59.2)
|
Heterosexual contact
|
54 (28.3)
|
Male homosexual contact
|
24 (12.5)
|
Treatment scheme, n (%)
| |
Untreated
|
51 (26.7)
|
Non-nucleoside analogues
|
76 (39.8)
|
Protease inhibitors
|
64 (33.5)
|
Undetectable HIV-1 viral load
a
, n (%)
|
114 (59.7)
|
CD4+ T lymphocyte count, cells/mL
|
459 (22.8)
|
HCV co-infection, n (%)
|
115 (60.2)
|
HCV genotypes, %
| |
I
|
78.3
|
II
|
3.8
|
III
|
14.9
|
IV
|
3.0
|
Log-HCV viral load, copies/mL
|
5.89 (1.14)
|